This is in contrast to the TRANSBIG validation study, where considerable heterogeneity in both estimated model coefficients for gene expression values and predictive accuracy existed between ER+ and ER- subsets of breast cancer (Figure 8, Additional file 6: Figure S4). The gene discussed is ESR1; the disease is breast carcinoma.